June 4, 2026 · Form 4 insider transaction
JOHNSON JOHN bought 32,996 shares of Xeris Biopharma Holdings, Inc. at $6.15 per share, a transaction worth $202.9K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date.